VSV-MP gene therapy (Shanghai Shyndec Pharmaceutical/Sichuan University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVSV-MP gene therapy (Shanghai Shyndec Pharmaceutical/Sichuan University)
Drug Alias Namevesicular stomatitis virus matrix protein plasmid gene therapy (Shanghai Shyndec Pharmaceutical/Sichuan University)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSichuan UniversityShanghai Shyndec Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A